The genetic complexity of MPNST was better understood after two independent studies highlighted the prominent role of Polycomb repressor complex 2 (PRC2) inactivation in the development of MPNST through somatic inactivating mutations or deletions in SUZ12, EED or EZH2 [10,11]. Here, EZH2 is linked to malignant peripheral nerve sheath tumor.